{"id":755096,"date":"2023-05-04T13:03:37","date_gmt":"2023-05-04T17:03:37","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/precipio-adds-substantial-pathology-customer-to-its-diagnostic-services-division\/"},"modified":"2023-05-04T13:03:37","modified_gmt":"2023-05-04T17:03:37","slug":"precipio-adds-substantial-pathology-customer-to-its-diagnostic-services-division","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/precipio-adds-substantial-pathology-customer-to-its-diagnostic-services-division\/","title":{"rendered":"Precipio Adds Substantial Pathology Customer to its Diagnostic Services Division"},"content":{"rendered":"<h2>\nCustomer\u2019s pathology services annual revenues expected to exceed $1.5M<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p align=\"justify\">NEW HAVEN, Conn., May  04, 2023  (GLOBE NEWSWIRE) &#8212; Specialty cancer diagnostics company\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=SoymxrKadAXfWEJZsALRbPu7C893mq3pak1e6nf97yvSUYsrsOlZbE9vydXFTyH61Xo5CfbtxuB70VmafWHf5w==\" rel=\"nofollow noopener\" target=\"_blank\"><u>Precipio, Inc.<\/u><\/a>\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=MiLWgXiBXIKW5-Uy1cE3lMeNqUGLj08vsKXkFzTzIhWcOLAR6RewMPE_ppoV-pMWLaj5w7EHLzKa7Z3NMfiy04dQXvAWH7taqTs9jR5z0E0=\" rel=\"nofollow noopener\" target=\"_blank\"><u>(NASDAQ: PRPO)<\/u><\/a> announces another agreement with a new pathology services customer to utilize Precipio\u2019s diagnostic services.<\/p>\n<p align=\"justify\">Based on the customer\u2019s size and expected volume, with the addition of this and other customers, Precipio anticipates that with the addition of this customer, the Company expects to reach approximately 80% of the division\u2019s breakeven goal of $14M run-rate in Q3-2023.<\/p>\n<p align=\"justify\">\u201cWe are delighted to see the continued adoption of the value proposition of our diagnostic services, bringing the highest level of diagnostic expertise to serve community oncologists\u201d, said Ilan Danieli, Precipio\u2019s CEO. \u201cThis represents yet another step towards this division\u2019s breakeven. Our team continues to work hard to grow our business and reach the goals for 2023. I am excited to see us move one big step closer to being financially self-supportive\u201d.<\/p>\n<p align=\"justify\">\n        <strong>About Precipio<\/strong>\n      <\/p>\n<p align=\"justify\">Precipio has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide, as well as proprietary products that serve laboratories worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zrp-7OkHbzSWo7rIjyrDjqFP1aKWaykxHqRmOpWv-IhGyws0OH07S0cpjmHbAs-z-ErWhN9KlWMkTBOVxaMmScIyCLKBf_U7o15pcVqyMv4=\" rel=\"nofollow noopener\" target=\"_blank\"><u>www.precipiodx.com<\/u><\/a>.<\/p>\n<p align=\"justify\">Please follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Evgh1Q7VN1xzIhTvSsE8S7QjDWuSaazwOeRTQ2ZjhFJzZ9BpB35eDsQsaS5rcGEXE_-oJG3P9b3uSKUtjlKaiD8rdXPupSk2fz7BhZNLxb02DOkjnYzfA3nk6zElFf54\" rel=\"nofollow noopener\" target=\"_blank\"><u>LinkedIn<\/u><\/a>, Twitter <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=tQNHGEY7vR8kmQP0rxqu7RG9dhw29rLQraE1IZu-9Ear3IuWy8_wfs9pFf5Cxx7jW_ZWS-iTgVNBRQDAUrt9PlGsDg8orOIHm1S0SORnJZg=\" rel=\"nofollow noopener\" target=\"_blank\"><u>@PrecipioDx<\/u><\/a> and on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8cvZG0jYMobYNwz8IMFzXRVNd27CtrPBm6qDqYpVuS1wPDOZYqip7GYbXJn4FI-IH8sHU8mCDg-3X85qvL5E_w==\" rel=\"nofollow noopener\" target=\"_blank\"><u>Facebook<\/u><\/a>.<\/p>\n<p align=\"justify\">\n        <strong>Forward-Looking Statements<\/strong>\n      <\/p>\n<p align=\"justify\">This press release contains \u201cforward-looking statements\u201d within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, among others, statements related to the expected or potential impact of the novel coronavirus (COVID-19) pandemic, and the related responses of the government, consumers, and the company, on our business, financial condition and results of operations, and any such forward-looking statements, whether concerning the COVID-19 pandemic or otherwise, involve risks, assumptions and uncertainties. Except for historical information, statements about future volumes, sales, growth, costs, cost savings, margins, earnings, earnings per share, diluted earnings per share, cash flows, plans, objectives, expectations, growth or profitability are forward-looking statements based on management\u2019s estimates, beliefs, assumptions and projections. Words such as \u201ccould,\u201d \u201cmay,\u201d \u201cexpects,\u201d \u201canticipates,\u201d \u201cwill,\u201d \u201ctargets,\u201d \u201cgoals,\u201d \u201cprojects,\u201d \u201cintends,\u201d \u201cplans,\u201d \u201cbelieves,\u201d \u201cseeks,\u201d \u201cestimates,\u201d \u201cpredicts,\u201d and variations on such words, and similar expressions that reflect our current views with respect to future events and operational, economic and financial performance, are intended to identify such forward-looking statements. These forward-looking statements are only predictions, subject to risks and uncertainties, and actual results could differ materially from those discussed. Important factors that could affect performance and cause results to differ materially from management\u2019s expectations, or could affect the company\u2019s ability to achieve its strategic goals, include the uncertainties relating to the impact of COVID-19 on the company\u2019s business, operations and employees and the other factors that are described in the sections entitled \u201cRisk Factors\u201d and \u201cManagement\u2019s Discussion and Analysis\u201d in the company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2021, as updated from time to time in the company\u2019s Securities and Exchange Commission filings.<\/p>\n<p align=\"justify\">The company\u2019s forward-looking statements in this press release are based on management\u2019s current views, beliefs, assumptions and expectations regarding future events and speak only as of the date of this release. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by the federal securities laws.\u00a0<\/p>\n<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMTYzMCM1NTc0Mjg5IzIwOTYwMTU=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/NGE0MWQwZDctODA0Mi00MzI5LWI0NzItNDgyOGZmNTRkZGY0LTExMDc1ODY=\/tiny\/Precipio-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\">\n<pre>Inquiries:\r\n\r\ninvestors@precipiodx.com\r\n\r\n+1-203-787-7888 Ext. 523<\/pre>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Customer\u2019s pathology services annual revenues expected to exceed $1.5M NEW HAVEN, Conn., May 04, 2023 (GLOBE NEWSWIRE) &#8212; Specialty cancer diagnostics company\u00a0Precipio, Inc.\u00a0(NASDAQ: PRPO) announces another agreement with a new pathology services customer to utilize Precipio\u2019s diagnostic services. Based on the customer\u2019s size and expected volume, with the addition of this and other customers, Precipio anticipates that with the addition of this customer, the Company expects to reach approximately 80% of the division\u2019s breakeven goal of $14M run-rate in Q3-2023. \u201cWe are delighted to see the continued adoption of the value proposition of our diagnostic services, bringing the highest level of diagnostic expertise to serve community oncologists\u201d, said Ilan Danieli, Precipio\u2019s CEO. \u201cThis represents yet another step towards this division\u2019s &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/precipio-adds-substantial-pathology-customer-to-its-diagnostic-services-division\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Precipio Adds Substantial Pathology Customer to its Diagnostic Services Division&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-755096","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Precipio Adds Substantial Pathology Customer to its Diagnostic Services Division - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/precipio-adds-substantial-pathology-customer-to-its-diagnostic-services-division\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Precipio Adds Substantial Pathology Customer to its Diagnostic Services Division - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Customer\u2019s pathology services annual revenues expected to exceed $1.5M NEW HAVEN, Conn., May 04, 2023 (GLOBE NEWSWIRE) &#8212; Specialty cancer diagnostics company\u00a0Precipio, Inc.\u00a0(NASDAQ: PRPO) announces another agreement with a new pathology services customer to utilize Precipio\u2019s diagnostic services. Based on the customer\u2019s size and expected volume, with the addition of this and other customers, Precipio anticipates that with the addition of this customer, the Company expects to reach approximately 80% of the division\u2019s breakeven goal of $14M run-rate in Q3-2023. \u201cWe are delighted to see the continued adoption of the value proposition of our diagnostic services, bringing the highest level of diagnostic expertise to serve community oncologists\u201d, said Ilan Danieli, Precipio\u2019s CEO. \u201cThis represents yet another step towards this division\u2019s &hellip; Continue reading &quot;Precipio Adds Substantial Pathology Customer to its Diagnostic Services Division&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/precipio-adds-substantial-pathology-customer-to-its-diagnostic-services-division\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-04T17:03:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMTYzMCM1NTc0Mjg5IzIwOTYwMTU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precipio-adds-substantial-pathology-customer-to-its-diagnostic-services-division\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precipio-adds-substantial-pathology-customer-to-its-diagnostic-services-division\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Precipio Adds Substantial Pathology Customer to its Diagnostic Services Division\",\"datePublished\":\"2023-05-04T17:03:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precipio-adds-substantial-pathology-customer-to-its-diagnostic-services-division\\\/\"},\"wordCount\":613,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precipio-adds-substantial-pathology-customer-to-its-diagnostic-services-division\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMTYzMCM1NTc0Mjg5IzIwOTYwMTU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precipio-adds-substantial-pathology-customer-to-its-diagnostic-services-division\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precipio-adds-substantial-pathology-customer-to-its-diagnostic-services-division\\\/\",\"name\":\"Precipio Adds Substantial Pathology Customer to its Diagnostic Services Division - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precipio-adds-substantial-pathology-customer-to-its-diagnostic-services-division\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precipio-adds-substantial-pathology-customer-to-its-diagnostic-services-division\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMTYzMCM1NTc0Mjg5IzIwOTYwMTU=\",\"datePublished\":\"2023-05-04T17:03:37+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precipio-adds-substantial-pathology-customer-to-its-diagnostic-services-division\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precipio-adds-substantial-pathology-customer-to-its-diagnostic-services-division\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precipio-adds-substantial-pathology-customer-to-its-diagnostic-services-division\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMTYzMCM1NTc0Mjg5IzIwOTYwMTU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMTYzMCM1NTc0Mjg5IzIwOTYwMTU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precipio-adds-substantial-pathology-customer-to-its-diagnostic-services-division\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Precipio Adds Substantial Pathology Customer to its Diagnostic Services Division\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Precipio Adds Substantial Pathology Customer to its Diagnostic Services Division - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/precipio-adds-substantial-pathology-customer-to-its-diagnostic-services-division\/","og_locale":"en_US","og_type":"article","og_title":"Precipio Adds Substantial Pathology Customer to its Diagnostic Services Division - Market Newsdesk","og_description":"Customer\u2019s pathology services annual revenues expected to exceed $1.5M NEW HAVEN, Conn., May 04, 2023 (GLOBE NEWSWIRE) &#8212; Specialty cancer diagnostics company\u00a0Precipio, Inc.\u00a0(NASDAQ: PRPO) announces another agreement with a new pathology services customer to utilize Precipio\u2019s diagnostic services. Based on the customer\u2019s size and expected volume, with the addition of this and other customers, Precipio anticipates that with the addition of this customer, the Company expects to reach approximately 80% of the division\u2019s breakeven goal of $14M run-rate in Q3-2023. \u201cWe are delighted to see the continued adoption of the value proposition of our diagnostic services, bringing the highest level of diagnostic expertise to serve community oncologists\u201d, said Ilan Danieli, Precipio\u2019s CEO. \u201cThis represents yet another step towards this division\u2019s &hellip; Continue reading \"Precipio Adds Substantial Pathology Customer to its Diagnostic Services Division\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/precipio-adds-substantial-pathology-customer-to-its-diagnostic-services-division\/","og_site_name":"Market Newsdesk","article_published_time":"2023-05-04T17:03:37+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMTYzMCM1NTc0Mjg5IzIwOTYwMTU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precipio-adds-substantial-pathology-customer-to-its-diagnostic-services-division\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precipio-adds-substantial-pathology-customer-to-its-diagnostic-services-division\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Precipio Adds Substantial Pathology Customer to its Diagnostic Services Division","datePublished":"2023-05-04T17:03:37+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precipio-adds-substantial-pathology-customer-to-its-diagnostic-services-division\/"},"wordCount":613,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precipio-adds-substantial-pathology-customer-to-its-diagnostic-services-division\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMTYzMCM1NTc0Mjg5IzIwOTYwMTU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precipio-adds-substantial-pathology-customer-to-its-diagnostic-services-division\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/precipio-adds-substantial-pathology-customer-to-its-diagnostic-services-division\/","name":"Precipio Adds Substantial Pathology Customer to its Diagnostic Services Division - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precipio-adds-substantial-pathology-customer-to-its-diagnostic-services-division\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precipio-adds-substantial-pathology-customer-to-its-diagnostic-services-division\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMTYzMCM1NTc0Mjg5IzIwOTYwMTU=","datePublished":"2023-05-04T17:03:37+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precipio-adds-substantial-pathology-customer-to-its-diagnostic-services-division\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/precipio-adds-substantial-pathology-customer-to-its-diagnostic-services-division\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precipio-adds-substantial-pathology-customer-to-its-diagnostic-services-division\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMTYzMCM1NTc0Mjg5IzIwOTYwMTU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMTYzMCM1NTc0Mjg5IzIwOTYwMTU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precipio-adds-substantial-pathology-customer-to-its-diagnostic-services-division\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Precipio Adds Substantial Pathology Customer to its Diagnostic Services Division"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/755096","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=755096"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/755096\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=755096"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=755096"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=755096"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}